16 years of the Cochrane Heart Group: The Cochrane Heart Group registered as an entity of the Cochrane Collaboration in July 1998.
The Cochrane Heart Group’s aim is to prepare, maintain and promote the access of systematic reviews of the effects of interventions for treating ischaemic and all other heart diseases and preventing cardiovascular diseases. We also aim to make the results of research assessing the effects of health care on heart diseases more easily available and more relevant to health care professionals, policy makers and to the general public.
The scope of the Cochrane Heart Group includes primary prevention, acute treatment, secondary prevention and rehabilitation, in all forms of heart disease, including ischaemic heart disease, heart diseases more common in developing countries, arrhythmias, valvular and congenital heart diseases.
We have 33 Editors and 830 authors across 5 continents who contribute to the Cochrane Heart Group. Our wide membership includes clinicians, researchers and healthcare consumers who share an interest in generating reliable, up-to-date evidence relevant to the prevention, treatment and rehabilitation of particular heart problems. Our work has contributed specifically to the following:
Evidence for national and international clinical/public health guideline development: Forty two per cent (50/116 Cochrane Heart Group Reviews) are cited in 65 different national and international guidelines.
Impact factor for Cochrane Heart Group; 9.268.
Systematic review training: We contribute to the LSHTM based annual systematic review short course. We have run courses in Systematic Reviews in South and South East Asia. We provide research support to specialist registrars doing Cochrane reviews.
- To strengthen our links with NICE and organisations in USA producing guidelines.
- To strengthen capacity in systematic reviews in low and middle income countries.
- Build dissemination of Cochrane material through links with general medical and cardiology journals
- Strengthen our existing collaborations with systematic review methodology research groups (currently with University of Bristol).
We are based at the Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, UK.
You can follow us on Twitter @CochraneHeart